Skip to contentSUTTER MARTIN P — ABIOMED INC insider: 361 transactions · InsiderLensSUTTER MARTIN P
- Director at LIFECELL CORP · on record since Jun 30, 2006
- Director at LA JOLLA PHARMACEUTICAL CO · on record since May 22, 2006
- Director at BIOFORM MEDICAL INC · on record since Nov 14, 2007
- 10% owner at BIOFORM MEDICAL INC · on record since Nov 14, 2007
- Director at ATS MEDICAL INC · on record since Dec 23, 2008
- 10% owner at ATS MEDICAL INC · on record since Dec 23, 2008
- Director at ABIOMED INC · on record since May 29, 2008
- Director at SONTRA MEDICAL CORP · on record since Sep 17, 2003
- Director at CELL THERAPEUTICS INC · on record since Nov 14, 2003
- Director at Bioventus Inc. · on record since Jun 4, 2026
- 10% owner at Bioventus Inc. · on record since Jun 4, 2026
- Director at ZONAGEN INC · on record since Feb 13, 2004
- Director at Alynx, Co. · on record since Aug 28, 2020
- 10% owner at Alynx, Co. · on record since Aug 28, 2020
- Director at KSW INC · on record since May 19, 2022
- Director at MICROMED CARDIOVASCULAR INC · on record since Aug 22, 2005
- 10% owner at MICROMED CARDIOVASCULAR INC · on record since Aug 22, 2005
Insider trading activity of SUTTER MARTIN P
- Transactions on record
- 361
- since Sep 17, 2003
- Open-market buys
- 15
- $35.7M
- Open-market sells
- 165
- $50.6M
- Companies traded
- 10
- last filing Jun 4, 2026
Figures computed from official regulatory filings — methodology.
Companies where SUTTER MARTIN P has traded
Track record of SUTTER MARTIN P
Statistical track record
Free- Open-market buys
- 20
- Last buy
- May 29, 2015
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of SUTTER MARTIN P
Co-insiders of SUTTER MARTIN P
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
1 tx · Nov 14, 2003
BVF PARTNERS L P/ILCELL THERAPEUTICS INC +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 4, 2026 | AwardD | 25,146 | 0.00 USD | $0 | SEC |
| Jun 4, 2026 | ExerciseD | -32,282 | 0.00 USD | $0 | SEC |
| Jun 4, 2026 | Exercise | 32,282 | 0.00 USD | $0 | SEC |
| Jun 4, 2025 | Exercise | 26,493 | 0.00 USD | $0 | SEC |
| Jun 4, 2025 | ExerciseD | -26,493 | 0.00 USD | $0 | SEC |
| Jun 4, 2025 | AwardD | 32,282 | 0.00 USD | $0 | SEC |
| Jun 13, 2024 | AwardD | 26,493 | 0.00 USD | $0 | SEC |
| Jun 11, 2024 | Exercise | 30,400 | 0.00 USD | $0 | SEC |
| Jun 11, 2024 | ExerciseD | -30,400 | 0.00 USD | $0 | SEC |
| Jun 13, 2023 | Exercise | 16,648 | 0.00 USD | $0 | SEC |
| Jun 13, 2023 | AwardD | 30,400 | 0.00 USD | $0 | SEC |
| Jun 13, 2023 | ExerciseD | -16,648 | 0.00 USD | $0 | SEC |
| Dec 27, 2022 | Other | -123,370 | — | — | SEC |
| Nov 17, 2022 | Sell | -141 | 375.56 USD | $53K | SEC |
| Nov 17, 2022 | Sell | -867 | 374.92 USD | $325.1K | SEC |
| Nov 17, 2022 | Sell | -1,859 | 374.66 USD | $696.5K | SEC |
| Nov 17, 2022 | Sell | -1,133 | 374.18 USD | $423.9K | SEC |
| Aug 17, 2022 | Sell | -285 | 288.44 USD | $82.2K | SEC |
| Aug 17, 2022 | Sell | -51 | 287.66 USD | $14.7K | SEC |
| Aug 17, 2022 | Sell | -483 | 290.60 USD | $140.4K | SEC |
| Aug 17, 2022 | Sell | -205 | 283.51 USD | $58.1K | SEC |
| Aug 17, 2022 | Sell | -785 | 281.52 USD | $221K | SEC |
| Aug 17, 2022 | Sell | -20 | 287.44 USD | $5.7K | SEC |
| Aug 17, 2022 | Sell | -78 | 286.49 USD | $22.3K | SEC |
| Aug 17, 2022 | Sell | -573 | 280.59 USD | $160.8K | SEC |